BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29516208)

  • 41. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
    Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
    Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution.
    Przybycin CG; Cronin AM; Darvishian F; Gopalan A; Al-Ahmadie HA; Fine SW; Chen YB; Bernstein M; Russo P; Reuter VE; Tickoo SK
    Am J Surg Pathol; 2011 Jul; 35(7):962-70. PubMed ID: 21602658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
    Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
    Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.
    Guo J; Tretiakova MS; Troxell ML; Osunkoya AO; Fadare O; Sangoi AR; Shen SS; Lopez-Beltran A; Mehra R; Heider A; Higgins JP; Harik LR; Leroy X; Gill AJ; Trpkov K; Campbell SC; Przybycin C; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2014 Nov; 38(11):1457-67. PubMed ID: 25093518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
    Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
    Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
    Yohannan J; Feng T; Berkowitz J; Connolly SS; Pierorazio P; Allaf ME
    J Endourol; 2010 Oct; 24(10):1609-12. PubMed ID: 20629564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic Features of Translocation Renal Cell Carcinoma.
    Ellati RT; Abukhiran I; Alqasem K; Jasser J; Khzouz J; Bisharat T; Al-Saidi I; Al-Daghmin A
    Clin Genitourin Cancer; 2017 Feb; 15(1):112-116. PubMed ID: 27372562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
    Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.
    Stephenson AJ; Chetner MP; Rourke K; Gleave ME; Signaevsky M; Palmer B; Kuan J; Brock GB; Tanguay S
    J Urol; 2004 Jul; 172(1):58-62. PubMed ID: 15201737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
    Väänänen T; Kallio J; Vuolteenaho K; Ojala A; Luukkaala T; Hämäläinen M; Tammela T; Kellokumpu-Lehtinen PL; Moilanen E
    Scand J Urol; 2017 Oct; 51(5):367-372. PubMed ID: 28644702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.
    Motzer RJ; Bacik J; Mariani T; Russo P; Mazumdar M; Reuter V
    J Clin Oncol; 2002 May; 20(9):2376-81. PubMed ID: 11981011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience.
    Carini M; Minervini A; Masieri L; Lapini A; Serni S
    Eur Urol; 2006 Dec; 50(6):1263-8; discussion 1269-71. PubMed ID: 16787695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study.
    Kang HW; Lee SK; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    J Surg Oncol; 2016 Jul; 114(1):70-4. PubMed ID: 27074886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solitary, late metastatic recurrence of renal cell carcinoma: two extraordinary cases.
    Featherstone JM; Bass P; Cumming J; Smart CJ
    Int J Urol; 2006 Dec; 13(12):1525-7. PubMed ID: 17118029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.